JAMA Author Interviews: Covering research in medicine, science,& clinical practice. For physicians, researchers,& clinicians.
Engaging and topical conversations with authors of research, clinical reviews, and opinion pieces published in JAMA. Subscribe for the latest information, ideas, and innovations in clinical medicine and health policy.
- Website
- http://jama.jamanetwork.com/multimedia.aspx#AuthorInterviews
- Description
- Engaging and topical conversations with authors of research, clinical reviews, and opinion pieces published in JAMA. Subscribe for the latest information, ideas, and innovations in clinical medicine and health policy.
- Language
- 🇬🇧 English
- last modified
- 2025-01-14 04:11
- last episode published
- 2025-01-13 16:00
- publication frequency
- 6.23 days
- Contributors
- The JAMA Network
- Author
- American Medical Association
- Owner
- Explicit
- false
- Number of Episodes
- 844
- Rss-Feeds
- Detail page
- Categories
- Medicine Science & Medicine Health & Fitness
Recommendations
Episodes
| Date | Title & Description | Contributors |
|---|---|---|
| 2025-01-13 |
Intra-Arterial Thrombolytics Following Thrombectomy for Ischemic Stroke Two new trials published in JAMA evaluate the efficacy of periprocedural intra-arterial thrombolytics after successful endovascular thrombectomy for patients with acute ischemic stroke. Diederik Dippel, MD, PhD, of Erasmus University Medical Center dis... |
|
| 2025-01-09 |
Impact of Private Equity Acquisition on Patient Care Experience in US Hospitals Private equity acquisitions of health care facilities have rapidly increased over the past decade. However, little is known about the effects of these acquisitions on patient experience. Author Rishi K. Wadhera, MD, MPP, MPhil, of Harvard Medical Schoo... |
|
| 2025-01-02 |
Asthma Endotypes Based on Nasal Epithelial Biopsies in School-Aged Youth Certain CD4+ T-cell subtypes play a role in asthma. Characterizing asthma endotypes in diverse groups is important to help develop effective therapies for youth with asthma. Author Juan C. Celedon, MD, DrPH, University of Pittsburgh, Department of Pedi... |
|
| 2024-12-26 | Most Medicare Advantage (MA) plans offer dental care coverage as a supplemental benefit. However,few beneficiaries are enrolled in an MA plan that provides comprehensive dental benefits. Lisa Simon, MD, DMD, discusses this and more with JAMA Deputy Edi... | |
| 2024-12-18 | Long COVID is now defined as a heterogeneous, infection-associated chronic condition present for at least 3 months after SARS-CoV-2 infection. Author Leora Horwitz, MD, MHS, of NYU Grossman School of Medicine joins JAMA Executive Editor Gregory Curfman... | |
| 2024-12-13 |
Camrelizumab vs Placebo With Chemotherapy as Neoadjuvant Treatment in Triple-Negative Breast Cancer Triple-negative breast cancer accounts for around 15% of breast cancers. Zhi-Ming Shao, MD, of Fudon University, joins JAMA Oncology Editor in Chief and JAMA Deputy Editor Nora Disis, MD, to discuss "Camrelizumab vs Placebo in Combination With Chemothe... |
|
| 2024-12-01 | New antiretroviral drugs and formulations continue to become available for the prevention and management of HIV infection. Author Rajesh T. Gandhi, MD, joins JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss these new approaches for HIV. Related C... | |
| 2024-11-25 | A new JAMA study examines the association between severe maternal morbidity in a first birth and the probability of a subsequent birth. Authors Neda Razaz, PhD, and Eleni Tsamantioti, MD, MMedSc, both from the Karolinska Institute in Sweden, discuss th... | |
| 2024-11-18 |
Zerlasiran, a Small-Interfering RNA That Targets Lipoprotein(a) Elevated lipoprotein(a) levels increase the risk of atherosclerotic cardiovascular disease (ASCVD) and aortic stenosis. Cleveland Clinic’s Steven E. Nissen, MD, speaks with JAMA Executive Editor Gregory Curfman, MD, about how zerlasiran produced more t... |
|
| 2024-11-11 | Preterm birth is the greatest cause of neonatal mortality and morbidity, with infants born extremely preterm at highest risk. Author Brett J. Manley, PhD, the Royal Women’s Hospital, Melbourne, Australia, discusses a new study of the effect of intratra... |